Superba Krill Oil Shows Benefits for ADHD
A clinical study in children with attention deficit hyperactivity disorder (ADHD) suggests that Superba krill oil from Aker BioMarine offered significant improvements in clinical scores and identified EEG patterns as compared to typical ADHD EEG patterns.
Eighteen boys (age 7-11 years) with ADHD received Superba krill oil daily for a period of 13 weeks. The EEG patterns for the study participants were compared to a database of more than 400 children with an established ADHD diagnosis to provide comparative data. For further information: www.akerbiomarine.com
Meriva May Reduce Eye Inflammation
A new study indicates Meriva, a patented complex of curcumin with soy phosphatidylcholine from Indena, helps reduce frequency and severity of relapses in patients with recurrent anterior uveitis (RAU).
Published in Clinical Ophthalmology, this study showed that Meriva could play an important role in the adjunctive therapy of RAU, the most common form of uveitis, a form of inflammation involving the interior of the eye that in some cases can lead to blindness. Symptoms of RAU--also termed iritis--include pain, redness, photophobia and, to a variable degree, decreased vision.
Researchers administered two tablets of Norflo (Eye Pharma Co), containing 600 mg of Meriva, for 12 months to 122 patients diagnosed with RAU for at least 2 years before the beginning of the trial, and during which they had suffered 1-4 relapses per year.
Among the 106 patients who completed the study, only 19 (18%) had relapses. An improvement in symptoms, including ocular pain and blurring of vision, was also observed, and 86% of patients reported a subjective systemic well-being, progressively developing after 4 to 6 weeks of treatment. For further Information: www.indena.com
Probiotic BB-12 May Reduce Respiratory Illness in Infants
Daily supplementation with Chr. Hansen's probiotic strain BB-12 may significantly reduce the occurrence of respiratory infections in early childhood, according to a federally-funded, clinical study published in the September issue of the British Journal of Nutrition.
In this double-blind, placebo-controlled study, 109 newborn infants were randomly assigned to a probiotic group receiving BB-12 or to a control group receiving placebo. BB-12 was administered to the healthy breastfed infants twice a day from the age of 1-2 months to 8 months with a pacifier or a spoon.
The main finding was that BB-12 reduced respiratory infections, as 65% of children in the BB-12 group and 94% in the control group had experienced one or more episodes of respiratory infections at the 8-month examination. For further information: www.chr-hansen.com
Study Shows Bioavailability of FloraGLO Lutein with Actilease
Kemin Health, L.C., creator of FloraGLO lutein, and DSM Nutritional Products recently presented new research demonstrating the bioavailability of FloraGLO lutein with Actilease technology.
Lutein bioavailability, or the delivery of the ingredient to the beneficial sites of action--including the macula where lutein is quantified as macular pigment optical density (MPOD)--is essential for eye health. Research supports that MPOD has the potential to become a commonly tested biomarker in the assessment of visual function and risk for eye disease.
FloraGLO lutein beadlets utilize Actilease beadlet technology, a branded, patented technology from DSM that formulates FloraGLO lutein into micro-sized particles that are protected in a water-soluble shell. Published research shows that FloraGLO lutein, with Actilease technology, is absorbed by the body into the bloodstream and, more importantly, deposited into the macula, increasing MPOD. For further information: www.kemin.com; www.dsmnutritionalproducts.com
Sharp-PS GOLD May Have Positive Effects on Memory
A new study published in the peer-reviewed journal Clinical Interventions in Aging indicates that phosphatidylserine containing omega 3 fatty acids (PS-omega 3) may have a favorable effect on memory recall in subjects with subjective memory complaints.
This pilot study tested the effect of PS-omega 3 (SharpThoughts--the commercial product containing Sharp-PS GOLD from Enzymotec) consumption on the memory abilities of elderly volunteers. Following supplementation with PS-omega 3, the ability to recall words after a delay improved by 42%.
Study findings indicate that Sharp-PS GOLD may have a beneficial effect on the ability to store, hold and retrieve information. For further information: www.enzymotec.com
Glucosamine Doesn't Impact Glucose Metabolism
A comprehensive review from a team of experts in diabetes and glucose metabolism recently concluded that consuming glucosamine as an oral supplement at typical levels does not adversely affect glucose metabolism in normal and diabetic individuals. The review has been accepted for publication in Diabetes Metabolism Research and Reviews.
The purpose of the review, commissioned by Cargill, was to investigate concerns that have been raised about glucosamine's purported effects on glucose tolerance in healthy people, and worsening of diabetes in the afflicted. Authors found the concentration of glucosamine in plasma is several orders of magnitude below what has been reported to impair glucose metabolism in vitro. For further information: www.cargill.com
Resveratrol Study to Investigate Metabolic Syndrome
The Danish Council for Strategic Research has granted more than $3 million for a research project that will investigate the use of resveratrol for management of metabolic syndrome, osteoporosis and inflammation in humans. Fluxome A/S will supply Fluxome Resveratrol for the trials.
The 5-year project starts in June 2011 and participants will consume resveratrol for 12 months. The objective of the project is to determine if resveratrol can neutralize the detrimental effect of obesity on the whole body metabolism such as low-grade chronic inflammation, insulin resistance and lipid infiltration/inflammation in liver and skeletal muscle. For further information: www.fluxome.com
Slimaluma May Curb Obesity
A study recently published in the Journal of Nutrition and Metabolism indicates Slimaluma (Caralluma fimbriata) extract, from Gencor Nutrients, has the potential to curb obesity and the pathologies linked to obesity.
This study evaluated the extract for appetite suppressing, antiobesogenic and antiatherogenic properties in a DIO rat model. Results showed pronounced dose-dependent appetite suppressant and antiobesogenic effects on a sample of rats fed a cafeteria diet. For further information: www.gencorpacific.com
Study to Analyze Magnesium, Whey Protein Relation to Physical Performance
Albion Human Nutrition has agreed to fund a new clinical study that will analyze the impact of magnesium creatine chelate (Creatine Magna Power), magnesium creatine chelate plus whey protein stack and placebo on physical performance.
The 10-week, double-blind study will be conducted under the direction of L.R. Brilla, PhD, at Western Washington University. Supplementation regimens will be conducted for 8 weeks. Baseline and ending information will include a 3-day dietary analysis and 3-day physical activity log to determine energy expenditure.
The physiological attribute tests include body composition, body water, muscle strength and power. Data will be collected before and after each treatment phase. Data analysis will determine if different supplementation regimens, inclusive of Creatine Magna Power affect variables associated with physical performance compared to regimens with or without protein stack and to placebo. For further information: www.albionminerals.com
0 comments:
Post a Comment